These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2870837

  • 21. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA.
    J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.
    Am J Cardiol; 1983 Dec 01; 52(10):1230-7. PubMed ID: 6359851
    [Abstract] [Full Text] [Related]

  • 23. Timolol and bendroflumethiazide in the treatment of hypertension.
    Karatzas NB, Papazachos G, Clouva P, Tsaknakis T.
    J Int Med Res; 1979 Dec 01; 7(3):215-20. PubMed ID: 378730
    [No Abstract] [Full Text] [Related]

  • 24. [Field trial with a new betablocker (Solgol)].
    Piergies A, Schimert G.
    MMW Munch Med Wochenschr; 1980 Oct 17; 122(42):1473-6. PubMed ID: 6110182
    [Abstract] [Full Text] [Related]

  • 25. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
    Felt V, Nedvídková J.
    Cas Lek Cesk; 1982 Mar 05; 121(9):266-8. PubMed ID: 6121628
    [No Abstract] [Full Text] [Related]

  • 26. [A new drug combination: metipranolol with butizide in the treatment of arterial hypertension].
    De Cesaris R, Balestrazzi M, Procaccio P, Dell'Orco M.
    Clin Ter; 1981 Oct 15; 99(1):43-7. PubMed ID: 6118217
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [The treatment of ambulant hypertensive patients with a combination of a saluretic and a beta-receptor blocker (author's transl)].
    Schlesinger P, Fadel Tabet F.
    MMW Munch Med Wochenschr; 1981 Oct 16; 123(42):1589-92. PubMed ID: 6118831
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Nadolol and placebo comparison study in the prophylactic treatment of migraine.
    Ryan RE, Ryan RE, Sudilovsky A.
    Panminerva Med; 1982 Oct 16; 24(2):89-94. PubMed ID: 6128710
    [No Abstract] [Full Text] [Related]

  • 32. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A, Coletta C, Carunchio A, Bordi L, Salustri A, Tornese C, Cigna G.
    Minerva Cardioangiol; 1985 Dec 16; 33(12):845-50. PubMed ID: 2869449
    [No Abstract] [Full Text] [Related]

  • 33. [Nadolol, a long-term acting beta blocking agent, in the treatment of essential arterial hypertension].
    Semplicini A, Pessina AC, Rossi GP, Tagliafierro R, Lusiani L, Castellani V, Bedogni F, Mazzucato A, Ronsisvalle G.
    Cardiologia; 1982 Sep 16; 27(9):853-64. PubMed ID: 6765278
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of nadolol in coronary disease].
    Krotkiewski A, Zatorski A, Jarecki M, Ruszkowski J, Szelemetko J.
    Pol Tyg Lek; 1980 Jun 02; 35(22):833-6. PubMed ID: 6106925
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
    Tirlapur VG, Mir MA.
    Postgrad Med J; 1983 Jun 02; 59 Suppl 2():30-4. PubMed ID: 6136959
    [Abstract] [Full Text] [Related]

  • 37. [Mitral valve prolapse. Evaluation of the efficacy of nadolol on the control of clinical symptoms and on the normalization of electrocardiographic tracings].
    Bichuette HS.
    Arq Bras Cardiol; 1984 Dec 02; 43(6):449-56. PubMed ID: 6152676
    [No Abstract] [Full Text] [Related]

  • 38. Nadolol and antidepressant response.
    Faber R.
    Biol Psychiatry; 1983 Nov 02; 18(11):1338-9. PubMed ID: 6140034
    [No Abstract] [Full Text] [Related]

  • 39. [Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension].
    Semplicini A, Pessina AC, Rossi GP, Tagliafierro R, Lusiani L, Castellani V, Bedogni F, Mazzucato A, Ronsisvalle G.
    Cardiologia; 1982 Sep 02; 27(9):853-64. PubMed ID: 6765448
    [No Abstract] [Full Text] [Related]

  • 40. [Evaluation of hypotensive effect of nadolol].
    Cybulska I, Brym E, Czerniewska E, Wołyńczyk-Niegowska J.
    Pol Arch Med Wewn; 1980 Dec 02; 64(6):475-80. PubMed ID: 6111065
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.